Study Finds Single-Country Oversight of Dual-Use Research Carries Structural Limits

A peer-reviewed study published in Science this month puts quantitative weight behind a tension that biosecurity policy circles have debated qualitatively for years: tightening national oversight of dual-use research may hurt domestic science more than it constrains the global risk.

<cite index="15-2,15-3">The new analysis of approximately 600,000 research papers, by Professor Seokbeom Kwon of KAIST's School of Business and Technology Management, examines the structural limitations of single-country security oversight of dual-use research and the trade-offs policymakers face when strengthening such oversight.</cite> <cite index="19-8,19-9">The sole-author paper, titled "Dual-use research under scrutiny," appeared in Science on June 5, 2026, with DOI 10.1126/science.aee2479.</cite>

<cite index="15-5">Dual-use research (DUR) covers scientific work with legitimate civilian applications, such as vaccine and treatment development, that also carries potential security-sensitive applications including biological weapons or bioterrorism.</cite> <cite index="16-5">Examples include research on viral transmission mechanisms or pathogen behavior.</cite> The governance question is not new, but Kwon's contribution is the scale of the evidence base.

<cite index="16-9,16-10">Kwon developed an analytical methodology combining the U.S. Patent and Trademark Office's multi-stage security review process with patent-paper citation data, and the work has been recognized for shifting discussions of dual-use research from case-based analysis toward large-scale empirical analysis.</cite> What the data show is uncomfortable on both sides of the oversight debate. <cite index="16-11,16-12">The analysis found that dual-use research consistently has greater scientific impact than comparable research, meaning the work subject to security oversight tends to play an important role in scientific progress and technological innovation.</cite>

That finding matters for calibrating oversight costs. <cite index="20-14,20-15,20-16">Recent U.S. policy developments have tightened national security oversight of dual-use research, and although such oversight is warranted given its security implications, these regulatory changes prompt critical questions about whether tightening security oversight yields proportional security benefits, since restrictive measures risk delaying diffusion of crucial scientific discoveries.</cite>

The U.S. regulatory backdrop has shifted considerably. <cite index="16-7,16-8">The United States has been strengthening security oversight of dual-use research, and most recently Executive Order 14292, signed in May 2025, intensified federal oversight of biological research with potential security implications, including dangerous gain-of-function research.</cite> But the existing framework has a jurisdiction gap that Kwon's paper makes explicit. <cite index="18-8,18-9">U.S. ex-ante security oversight institutions are based on National Security Decision Directive 189 and apply when the federal government is involved in research, meaning research conducted without federal government involvement effectively falls outside the jurisdiction of this oversight.</cite>

Kwon's policy conclusion, stated in the KAIST announcement reviewed by ETL Newswire, is that <cite index="15-6">"strengthening security oversight on dual-use research by a single country alone may impose disproportionate costs on domestic science, while having structural limits in preventing the development of equally important research conducted overseas," and that international cooperation and balanced policy design could help mitigate these structural tensions.</cite> That's a moderate-confidence assessment framed as an empirical finding, not a prescription, and the paper stops short of recommending specific oversight rollbacks.

The study lands at a moment when U.S. federal biosecurity capacity is under separate pressure. <cite index="4-1">The Trump administration's fiscal year 2026 budget proposed cuts to NIH of negative $18 billion, to the CDC of negative $3.6 billion, and to the Administration for Strategic Preparedness and Response of negative $240 million.</cite> <cite index="4-2">Those cuts coincide with dwindling staff across key federal biosecurity agencies and a leaderless White House Office of Pandemic Preparedness and Response Policy following the resignation of top official Gerald Parker.</cite>

Meanwhile, the dual-use tension Kwon's paper describes is also surfacing in the design of new international tools. <cite index="22-1,22-2">CEPI's Pandemic Preparedness Engine for Disease X, when fully operational, will incorporate agentic AI capabilities to accelerate vaccine development, spanning pathogen surveillance through regulatory submission.</cite> <cite index="22-4">CEPI has acknowledged the potentially serious biosecurity risks that new biological AI systems pose if intentionally misused by malicious actors.</cite> In a statement on the CEPI website, Director of Biosecurity Andrew Hebbeler was quoted saying that <cite index="27-3">"the same AI tools that can be used to design life-saving vaccines could also be misused to cause harm."</cite>

What the KAIST paper and the CEPI effort share is an honest acknowledgment that dual-use ambiguity can't be resolved by drawing tighter circles around one country's labs. The jurisdictional gap Kwon's data expose is real, and patching it unilaterally, the paper argues, costs more than it buys. That's a low-cost claim to publish in Science. Convincing governments to fund the multilateral alternative is harder work.

Sources cited:
- Science (DOI: 10.1126/science.aee2479) (https://www.science.org/doi/10.1126/science.aee2479)
- KAIST News Center (https://news.kaist.ac.kr/newsen/html/news/)
- EurekAlert / KAIST press release (https://www.eurekalert.org/news-releases/1131017)
- Homeland Security Newswire (https://www.homelandsecuritynewswire.com/dr20260608-first-largescale-empirical-analysis-of-dualuse-research-and-security-oversight)
- CSIS, Opportunities to Strengthen U.S. Biosecurity from AI-Enabled Bioterrorism (https://www.csis.org/analysis/opportunities-strengthen-us-biosecurity-ai-enabled-bioterrorism-what-policymakers-should)
- CEPI, Biosecurity-by-design for CEPI's Pandemic Preparedness Engine (https://cepi.net/biosecurity-design-cepis-pandemic-preparedness-engine)
- CEPI, Securing the Pandemic Preparedness Engine (https://cepi.net/securing-pandemic-preparedness-engine)